Core Laboratories Inc. /DE/
CLBUS売上高
$527M
百万USD
営業利益
$56M
百万USD
純利益
$30M
百万USD
ROE
11.2%
最新FY
EPS
$0.63
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2023 | Q2 | $128M | $23M | $0.48 |
| FY2023 | Q3 | $125M | $9M | $0.19 |
| FY2023 | FY | $510M | $37M | $0.77 |
| FY2024 | Q1 | $130M | $3M | $0.07 |
| FY2024 | Q2 | $131M | $9M | $0.19 |
| FY2024 | Q3 | $134M | $12M | $0.25 |
| FY2024 | FY | $524M | $31M | $0.66 |
| FY2025 | Q1 | $124M | $-0M | $0.00 |
| FY2025 | Q2 | $130M | $11M | $0.22 |
| FY2025 | Q3 | $135M | $14M | $0.30 |
| FY2025 | FY | $527M | $30M | $0.63 |
| FY2026 | Q1 | $122M | $-1M | $-0.02 |
財務データ
| 指標 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| 売上高 | $510M | $524M | $527M |
| 営業利益 | $55M | $59M | $56M |
| 純利益 | $37M | $31M | $30M |
| 総資産 | $586M | $590M | $584M |
| 純資産 | $230M | $258M | $272M |
| 自己資本 | $225M | $252M | $266M |
| 営業CF | $25M | $56M | $37M |
| EPS | $0.77 | $0.66 | $0.63 |
| BPS | $4.80 | $5.38 | $5.78 |
| ROE | 16.3% | 12.5% | 11.2% |